Literature DB >> 24412578

Dynamic profiles of neutralizing antibody responses elicited in rhesus monkeys immunized with a combined tetravalent DTaP-Sabin IPV candidate vaccine.

Mingbo Sun1, Yan Ma2, Yinhua Xu3, Huijuan Yang2, Li Shi2, Yanchun Che2, Guoyang Liao2, Shude Jiang2, Shumin Zhang4, Qihan Li5.   

Abstract

The World Health Organization has recommended that a Sabin inactivated polio vaccine (IPV) should gradually and synchronously replace oral polio vaccines for routine immunizations because its benefits in eliminating vaccine-associated paralytic poliomyelitis have been reported in different phases of clinical trials. It is also considered important to explore new tetravalent diphtheria, tetanus, and acellular pertussis-Sabin IPV (DTaP-sIPV) candidate vaccines for possible use in developing countries. In this study, the immunogenicity of a combined tetravalent DTaP-sIPV candidate vaccine was investigated in primates by evaluating the neutralizing antibody responses it induced. The dynamic profiles of the antibody responses to each of the separate antigenic components and serotypes of Sabin IPV were determined and their corresponding geometric mean titers were similar to those generated by the tetravalent diphtheria, tetanus, and acellular pertussis-conventional IPV (DTaP-cIPV), the tetravalent diphtheria, tetanus, and acellular pertussis (DTaP), and Sabin IPV vaccines in the control groups. This implies that protective immunogenic effects are conferred by this combined tetravalent formulation.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DTaP-Sabin IPV; Immunogenicity; Rhesus monkey

Mesh:

Substances:

Year:  2014        PMID: 24412578     DOI: 10.1016/j.vaccine.2013.12.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Intranasal Immunization With a c-di-GMP-Adjuvanted Acellular Pertussis Vaccine Provides Superior Immunity Against Bordetella pertussis in a Mouse Model.

Authors:  Wenwen Jiang; Xiaoyu Wang; Yuhao Su; Lukui Cai; Jingyan Li; Jiangli Liang; Qin Gu; Mingbo Sun; Li Shi
Journal:  Front Immunol       Date:  2022-04-13       Impact factor: 8.786

2.  Nasal Infection of Enterovirus D68 Leading to Lower Respiratory Tract Pathogenesis in Ferrets (Mustela putorius furo).

Authors:  Hui-Wen Zheng; Ming Sun; Lei Guo; Jing-Jing Wang; Jie Song; Jia-Qi Li; Hong-Zhe Li; Ruo-Tong Ning; Ze-Ning Yang; Hai-Tao Fan; Zhan-Long He; Long-Ding Liu
Journal:  Viruses       Date:  2017-05-10       Impact factor: 5.048

3.  Deficits in the IgG+ memory B-cell recovery after anthracycline treatment is confined to the spleen of rhesus macaques.

Authors:  Gintare Lasaviciute; Andréas L Bricaud; Fredrika Hellgren; Hanna M Ingelman-Sundberg; Staffan Eksborg; Margreet Jonker; Krista G Haanstra; Ida Hed Myrberg; Eva Sverremark-Ekström; Karin Loré; Shanie Saghafian-Hedengren; Anna Nilsson
Journal:  Clin Transl Immunology       Date:  2020-07-02

4.  An inactivated poliovirus vaccine using Sabin strains produced on the serum-free PER.C6® cell culture platform is immunogenic and safe in a non-human primate model.

Authors:  Viki Bockstal; Machteld M Tiemessen; Rogier Achterberg; Carlo Van Wordragen; Ad M Knaapen; Jan Serroyen; Wilfred E Marissen; Hanneke Schuitemaker; Roland Zahn
Journal:  Vaccine       Date:  2018-10-09       Impact factor: 3.641

5.  Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model.

Authors:  Xiaoyu Wang; Na Gao; Jiana Wen; Jingyan Li; Yan Ma; Mingbo Sun; Jiangli Liang; Li Shi
Journal:  Vaccines (Basel)       Date:  2021-12-30

6.  Single B cells reveal the antibody responses of rhesus macaques immunized with an inactivated enterovirus D68 vaccine.

Authors:  Huiwen Zheng; Zening Yang; Bingxiang Li; Heng Li; Lei Guo; Jie Song; Dongpei Hou; Nan Li; Jinxi Yang; Qiongwen Wu; Ming Sun; Longding Liu
Journal:  Arch Virol       Date:  2020-05-28       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.